Loading market dashboard
InfuSystem Holdings, Inc.
INFUHealthcareAMEXUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
The consensus price target hints at a 62.6% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
InfuSystems Holdings (INFU) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
InfuSystems Holdings (INFU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
InfuSystems Holdings (INFU) possesses solid growth attributes, which could help it handily outperform the market.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces $20 Million Stock Repurchase Program.
InfuSystem Holdings, Inc. (INFU) Shareholder/Analyst Call Prepared Remarks Transcript
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
InfuSystem Holdings, Inc. (INFU) Q1 2026 Earnings Call Transcript
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to a loss of $0.01 per share a year ago.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for First Quarter 2026.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026.
InfuSystem Holdings, Inc. (NYSE: INFU - Get Free Report) was down 1.3% during trading on Thursday. The stock traded as low as $10.22 and last traded at $10.27. Approximately 75,645 shares traded hands during trading, a decline of 38% from the average daily volume of 122,904 shares. The stock had previously closed at $10.41. Analyst
My coverage for InfuSystem continues, focusing on recent developments and strategic positioning. INFU has made key operational improvements, has solid growth initiatives, and has the potential for continued strong revenue and earnings gains. InfuSystem's above-average growth has the potential to drive the stock for above-average long-term gains.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026.
InfuSystem (NYSE: INFU - Get Free Report) and Nemaura Medical (OTCMKTS:NMRD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Profitability This table compares InfuSystem and Nemaura Medical's net
